RAPAGEN
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Mar 2015)
What this means for you
This application is over — abandoned 23 Mar 2015. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85512500
- Mark type
- Stylized text
- Filed
- 10 Jan 2012
- Published for opposition
- 19 Jun 2012
- Abandoned
- 23 Mar 2015
- Attorney of record
- Michael Bamberger
Goods and services
- Class 005 — Pharmaceuticals: A combination drug product, namely, a formulation of sirolimus incorporated within a collagen membrane, which, as an implantable drug carrier, enables local delivery of sirolimus to the vascular wall
Owner
- VASCULAR THERAPIES, INC., CRESSKILL, NJ, US
- Vascular Therapies, LLC, Cresskill, NJ, US
- Vascular Therapies, LLC, Cresskill, NJ, US
Prosecution history
- 23 Mar 2015 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 23 Mar 2015 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Aug 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2014 — SOU EXTENSION 4 GRANTED
- 07 Aug 2014 — SOU EXTENSION 4 FILED
- 07 Aug 2014 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2014 — SOU EXTENSION 3 GRANTED
- 14 Feb 2014 — SOU EXTENSION 3 FILED
- 20 Feb 2014 — NOTICE OF REVIVAL - E-MAILED
- 20 Feb 2014 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 20 Feb 2014 — PETITION TO REVIVE-GRANTED
- 20 Feb 2014 — TEAS PETITION TO REVIVE RECEIVED
- 04 Sept 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2013 — SOU EXTENSION 2 GRANTED